The VEGF pathway is demonstrated to be crucial in HHT since its blockade by monoclonal antibodies or tyrosine kinase inhibitors significantly improve epistaxis, digestive bleeding, and high-output heart failure (25, 26). Here, VEGFA is linked to hereditary hemorrhagic telangiectasia.